Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles
- PMID: 15948217
- DOI: 10.1002/eji.200526059
Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles
Abstract
Virus-like particles containing the rotavirus (RV) internal proteins VP2 and VP6 (2/6-VLP) have been shown to induce serum and fecal antibodies as well as protection in mice after intranasal administration with a mutant of E. coli toxin, LT-R192G. To better understand the origin of fecal IgA induced by this protocol, we studied the RV-specific B cell response in systemic and mucosal lymphoid tissues using a flow cytometry assay that allows quantification and phenotypic characterization of RV-specific B lymphocytes. We also assessed the RV-specific antibody-secreting cells in the spleen and intestinal lamina propria (ILP). A remarkably high frequency of RV-specific B cells was found in the respiratory lymphoid tissues and spleen, of which only a minority expressed the alpha4beta7 integrin (intestinal homing receptor). In contrast, but in accordance with alpha4beta7 expression at the induction site, a very low response was observed in intestinal lymphoid tissues (mesenteric lymph nodes and ILP), which did not increase after a second immunization. Thus, intranasal immunization with a nonreplicating antigen does not induce an important number of RV-specific B cells with an intestinal homing profile.
Similar articles
-
Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.J Virol. 2006 Feb;80(4):1752-61. doi: 10.1128/JVI.80.4.1752-1761.2006. J Virol. 2006. PMID: 16439532 Free PMC article.
-
Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes.J Leukoc Biol. 2007 Oct;82(4):821-8. doi: 10.1189/jlb.0307173. Epub 2007 Jul 25. J Leukoc Biol. 2007. PMID: 17652448
-
Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.J Immunol. 1999 Sep 15;163(6):3064-70. J Immunol. 1999. PMID: 10477570
-
Immunity to rotavirus infection in mice.J Infect Dis. 1999 May;179 Suppl 3:S466-9. doi: 10.1086/314805. J Infect Dis. 1999. PMID: 10099121 Review.
-
[Pseudo-particles of rotavirus: properties and prospects of utilization].Vet Res. 1995;26(3):208-9. Vet Res. 1995. PMID: 7795678 Review. French. No abstract available.
Cited by
-
Cholera-like enterotoxins and Regulatory T cells.Toxins (Basel). 2010 Jul;2(7):1774-95. doi: 10.3390/toxins2071774. Epub 2010 Jul 6. Toxins (Basel). 2010. PMID: 22069660 Free PMC article. Review.
-
Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.J Virol. 2006 Apr;80(8):3823-32. doi: 10.1128/JVI.80.8.3823-3832.2006. J Virol. 2006. PMID: 16571799 Free PMC article.
-
Immunity to enteric viruses.Immunity. 2022 May 10;55(5):800-818. doi: 10.1016/j.immuni.2022.04.007. Immunity. 2022. PMID: 35545029 Free PMC article. Review.
-
Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.J Virol. 2006 Feb;80(4):1752-61. doi: 10.1128/JVI.80.4.1752-1761.2006. J Virol. 2006. PMID: 16439532 Free PMC article.
-
Development of a Bacillus subtilis-based rotavirus vaccine.Clin Vaccine Immunol. 2010 Nov;17(11):1647-55. doi: 10.1128/CVI.00135-10. Epub 2010 Sep 1. Clin Vaccine Immunol. 2010. PMID: 20810679 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous